1,962
+1.82%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Noritsu Koki Co
Its shares trade on Tokyo Stock Exchange under the ticker 7744.T. It has been listed since 14 February 1996. In the fiscal year to 31 December 2024, it reported revenue of ¥106.54bn and net income of ¥16.12bn. At that date it held total assets of ¥299.37bn and shareholders' equity of ¥222.25bn.
Noritsu Koki Co., Ltd. engages in the manufacture and sale of environment solution, kitchen, and photo processing equipment. The company is headquartered in Minato-Ku, Tokyo-To. The firm operates in six business segments. The Manufacturing segment is engaged in the research, development and manufacture of pen nib parts and cosmetics materials, among others. The Healthcare segment is engaged in the research, development and sale of radiological business support services by remote diagnostic imaging in the healthcare area, the analysis of received data and the provision of survey data, among others. The Drug Discovery segment develops new products in biotechnology area. The Senior and Life segment conducts senior publishing and mail order sales business. The Agri-food segment conducts the production and sale of fresh vegetables in the agri-food field. The Others segment conducts new growth related survey and investment business.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Industrials
- Industry
- Industrial Conglomerates
- Listed since
- 14 Feb 1996
- Employees
- 1,184
- Website
- noritsu.co.jp ↗
Leadership
Pay as last reported
- Mr. Ryukichi IwakiriChief Executive Officer, Representative Director, since 2018¥171.0m
- Mr. Ryosuke YokobariChief Financial Officer, Director, since 2020
- Ms. Yukiko KatabeExecutive Officer, Director of Business Administration, Director of Human Resources and General Affairs
- Mr. Megumi IwamotoExecutive Officer
- Mr. Motoaki IbanoIndependent Director
- Ms. Kazue MuraseIndependent Director
- Mr. Akihisa OtaIndependent Director
- Mr. Tsuyoshi TakadaIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- The Manufacturing segment develops pen nib parts and cosmetics materials for diverse markets.
- The Healthcare segment provides remote diagnostic imaging services to support radiological business operations.
- The Drug Discovery segment focuses on developing new products within the biotechnology area.
Weaknesses
- The Senior and Life segment relies on traditional senior publishing and mail order sales.
- The Agri-food segment produces fresh vegetables which may face seasonal supply chain challenges.
- The Others segment conducts new growth related survey and investment business with uncertain returns.
Opportunities
- The Healthcare segment can expand remote diagnostic imaging services to reach more patients globally.
- The Drug Discovery segment has potential to launch innovative biotechnology products in emerging markets.
- The Manufacturing segment can leverage pen nib parts expertise to enter new industrial sectors.
Threats
- The Agri-food segment faces risks from fluctuating weather conditions affecting fresh vegetable production.
- The Senior and Life segment may lose customers due to declining demand for print media.
- The Healthcare segment encounters competition from other providers of radiological business support services.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.